Hospital Outcome of Moderate to Severe Pericardial Effusion Complicating ST-Elevation Acute Myocardial Infarction

Hospital prognosis of moderate to severe pericardial effusion (MPE; ≥10 mm) in ST-elevation myocardial infarction is largely unknown. Data from 446 ST-elevation myocardial infarction patients, 228 with MPE-88 with cardiac tamponade (CT) and electromechanical dissociation (EMD), 44 with CT without EM...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 122; no. 19; pp. 1902 - 1909
Main Authors Figueras, Jaume, Barrabés, José A., Serra, Vicens, Cortadellas, Josefa, Lidón, Rosa-Maria, Carrizo, Alvaro, Garcia-Dorado, David
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 09.11.2010
Subjects
Online AccessGet full text
ISSN0009-7322
1524-4539
1524-4539
DOI10.1161/CIRCULATIONAHA.109.934968

Cover

Abstract Hospital prognosis of moderate to severe pericardial effusion (MPE; ≥10 mm) in ST-elevation myocardial infarction is largely unknown. Data from 446 ST-elevation myocardial infarction patients, 228 with MPE-88 with cardiac tamponade (CT) and electromechanical dissociation (EMD), 44 with CT without EMD (w/oEMD), and 96 without initial CT-and 218 with small PE (5 to 9 mm), were compared. Patients with MPE without initial CT were also compared with 96 patients without PE. CT patients showed larger PE (P<0.001) than those without initial CT; 85% of those with CT+EMD and 86% with CTw/oEMD were treated with pericardiocentesis and 10% and 21% were treated with a surgical repair, respectively. Among MPE patients, 30-day mortality was 43% and was higher in those with CT+EMD (operated, 89%; and nonoperated, 85%) than in those with CTw/oEMD (22% and 11%, respectively; P<0.001) and those without initial CT (17%; P<0.001). It was also higher than in patients with small PE (10%; P<0.001) or those without PE (6%; P=0.001). Death was attributable to cardiac rupture in 83% of patients with CT+EMD, 7% with CTw/oEMD, and 8% with MPE without initial CT and occurred late (≥7 days) in 14%, 67%, and 100%, respectively. MPE carries an increased mortality that is highest in patients with CT+EMD. In those with CTw/oEMD, however, mortality is considerably low after pericardiocentesis, and subsequent management may be individualized because a conservative approach is often successful. Importantly, MPE patients without initial CT are not free from late rupture and deserve further investigation.
AbstractList Hospital prognosis of moderate to severe pericardial effusion (MPE; ≥10 mm) in ST-elevation myocardial infarction is largely unknown. Data from 446 ST-elevation myocardial infarction patients, 228 with MPE-88 with cardiac tamponade (CT) and electromechanical dissociation (EMD), 44 with CT without EMD (w/oEMD), and 96 without initial CT-and 218 with small PE (5 to 9 mm), were compared. Patients with MPE without initial CT were also compared with 96 patients without PE. CT patients showed larger PE (P<0.001) than those without initial CT; 85% of those with CT+EMD and 86% with CTw/oEMD were treated with pericardiocentesis and 10% and 21% were treated with a surgical repair, respectively. Among MPE patients, 30-day mortality was 43% and was higher in those with CT+EMD (operated, 89%; and nonoperated, 85%) than in those with CTw/oEMD (22% and 11%, respectively; P<0.001) and those without initial CT (17%; P<0.001). It was also higher than in patients with small PE (10%; P<0.001) or those without PE (6%; P=0.001). Death was attributable to cardiac rupture in 83% of patients with CT+EMD, 7% with CTw/oEMD, and 8% with MPE without initial CT and occurred late (≥7 days) in 14%, 67%, and 100%, respectively. MPE carries an increased mortality that is highest in patients with CT+EMD. In those with CTw/oEMD, however, mortality is considerably low after pericardiocentesis, and subsequent management may be individualized because a conservative approach is often successful. Importantly, MPE patients without initial CT are not free from late rupture and deserve further investigation.
Hospital prognosis of moderate to severe pericardial effusion (MPE; ≥10 mm) in ST-elevation myocardial infarction is largely unknown.BACKGROUNDHospital prognosis of moderate to severe pericardial effusion (MPE; ≥10 mm) in ST-elevation myocardial infarction is largely unknown.Data from 446 ST-elevation myocardial infarction patients, 228 with MPE-88 with cardiac tamponade (CT) and electromechanical dissociation (EMD), 44 with CT without EMD (w/oEMD), and 96 without initial CT-and 218 with small PE (5 to 9 mm), were compared. Patients with MPE without initial CT were also compared with 96 patients without PE. CT patients showed larger PE (P<0.001) than those without initial CT; 85% of those with CT+EMD and 86% with CTw/oEMD were treated with pericardiocentesis and 10% and 21% were treated with a surgical repair, respectively. Among MPE patients, 30-day mortality was 43% and was higher in those with CT+EMD (operated, 89%; and nonoperated, 85%) than in those with CTw/oEMD (22% and 11%, respectively; P<0.001) and those without initial CT (17%; P<0.001). It was also higher than in patients with small PE (10%; P<0.001) or those without PE (6%; P=0.001). Death was attributable to cardiac rupture in 83% of patients with CT+EMD, 7% with CTw/oEMD, and 8% with MPE without initial CT and occurred late (≥7 days) in 14%, 67%, and 100%, respectively.METHODS AND RESULTSData from 446 ST-elevation myocardial infarction patients, 228 with MPE-88 with cardiac tamponade (CT) and electromechanical dissociation (EMD), 44 with CT without EMD (w/oEMD), and 96 without initial CT-and 218 with small PE (5 to 9 mm), were compared. Patients with MPE without initial CT were also compared with 96 patients without PE. CT patients showed larger PE (P<0.001) than those without initial CT; 85% of those with CT+EMD and 86% with CTw/oEMD were treated with pericardiocentesis and 10% and 21% were treated with a surgical repair, respectively. Among MPE patients, 30-day mortality was 43% and was higher in those with CT+EMD (operated, 89%; and nonoperated, 85%) than in those with CTw/oEMD (22% and 11%, respectively; P<0.001) and those without initial CT (17%; P<0.001). It was also higher than in patients with small PE (10%; P<0.001) or those without PE (6%; P=0.001). Death was attributable to cardiac rupture in 83% of patients with CT+EMD, 7% with CTw/oEMD, and 8% with MPE without initial CT and occurred late (≥7 days) in 14%, 67%, and 100%, respectively.MPE carries an increased mortality that is highest in patients with CT+EMD. In those with CTw/oEMD, however, mortality is considerably low after pericardiocentesis, and subsequent management may be individualized because a conservative approach is often successful. Importantly, MPE patients without initial CT are not free from late rupture and deserve further investigation.CONCLUSIONSMPE carries an increased mortality that is highest in patients with CT+EMD. In those with CTw/oEMD, however, mortality is considerably low after pericardiocentesis, and subsequent management may be individualized because a conservative approach is often successful. Importantly, MPE patients without initial CT are not free from late rupture and deserve further investigation.
Author Serra, Vicens
Figueras, Jaume
Garcia-Dorado, David
Carrizo, Alvaro
Barrabés, José A.
Cortadellas, Josefa
Lidón, Rosa-Maria
Author_xml – sequence: 1
  givenname: Jaume
  surname: Figueras
  fullname: Figueras, Jaume
  organization: From the Unitat Coronària, Servei de Cardiologia. Hospital Universitari Vall d'Hebron, Barcelona, Spain
– sequence: 2
  givenname: José A.
  surname: Barrabés
  fullname: Barrabés, José A.
  organization: From the Unitat Coronària, Servei de Cardiologia. Hospital Universitari Vall d'Hebron, Barcelona, Spain
– sequence: 3
  givenname: Vicens
  surname: Serra
  fullname: Serra, Vicens
  organization: From the Unitat Coronària, Servei de Cardiologia. Hospital Universitari Vall d'Hebron, Barcelona, Spain
– sequence: 4
  givenname: Josefa
  surname: Cortadellas
  fullname: Cortadellas, Josefa
  organization: From the Unitat Coronària, Servei de Cardiologia. Hospital Universitari Vall d'Hebron, Barcelona, Spain
– sequence: 5
  givenname: Rosa-Maria
  surname: Lidón
  fullname: Lidón, Rosa-Maria
  organization: From the Unitat Coronària, Servei de Cardiologia. Hospital Universitari Vall d'Hebron, Barcelona, Spain
– sequence: 6
  givenname: Alvaro
  surname: Carrizo
  fullname: Carrizo, Alvaro
  organization: From the Unitat Coronària, Servei de Cardiologia. Hospital Universitari Vall d'Hebron, Barcelona, Spain
– sequence: 7
  givenname: David
  surname: Garcia-Dorado
  fullname: Garcia-Dorado, David
  organization: From the Unitat Coronària, Servei de Cardiologia. Hospital Universitari Vall d'Hebron, Barcelona, Spain
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23437314$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20975001$$D View this record in MEDLINE/PubMed
BookMark eNqFkU-P0zAQxS20iO0ufAUUDmhPKf4bxycURYVW6lLEds-R44yRURJ37WSl_fa4aisEF07WzPzesz3vBl2NfgSEPhC8JKQgn-rNj_pxW-03u2_VuloSrJaKcVWUr9CCCMpzLpi6QguMscolo_Qa3cT4K5UFk-INuqZYSYExWaCntY8HN-k-282T8QNk3mb3voOgJ8gmnz3AMwTIvkNwRofOJXJl7RydH7PaD4c-tSc3_swe9vmqh-dUpEll5iS_f_EXzWa0Opjj7C16bXUf4d35vEWPX1b7ep1vd183dbXNDVNyypU2vIT03la3vKQt0bIUVnBatphgYUFTI6kgvBC4xLYDRsBiCbrocGclY7fo7uR7CP5phjg1g4sG-l6P4OfYyIJRIQWliXx_Jud2gK45BDfo8NJctpSAj2dAR6N7G_RoXPzDMc4kIzxxn0-cCT7GALYxabXHT09Bu74huDnm1_ydX2qr5pRfclD_OFwu-b_2Nz-codo
CODEN CIRCAZ
CitedBy_id crossref_primary_10_1007_s00109_011_0847_y
crossref_primary_10_1016_j_ijcard_2011_10_051
crossref_primary_10_1016_j_mehy_2020_109938
crossref_primary_10_1016_j_hrtlng_2022_10_002
crossref_primary_10_35366_95586
crossref_primary_10_1016_j_recesp_2011_10_031
crossref_primary_10_1155_2013_365623
crossref_primary_10_17656_jsmc_10154
crossref_primary_10_1016_j_rcl_2018_09_001
crossref_primary_10_7759_cureus_33773
crossref_primary_10_1016_j_ajem_2016_12_033
crossref_primary_10_1016_j_med_2017_06_021
crossref_primary_10_1016_j_rec_2021_03_012
crossref_primary_10_2174_1570161120666220721094739
crossref_primary_10_1016_j_jjcc_2018_02_008
crossref_primary_10_4997_jrcpe_2020_407
crossref_primary_10_1093_eurheartj_ehv318
crossref_primary_10_1016_j_amjcard_2013_11_071
crossref_primary_10_1007_s00415_012_6501_y
crossref_primary_10_1177_2048872619884858
crossref_primary_10_1016_j_ijrobp_2022_08_031
crossref_primary_10_15829_1560_4071_2023_5398
crossref_primary_10_1111_echo_13202
crossref_primary_10_1111_joic_12563
crossref_primary_10_1016_j_mayocp_2019_06_016
crossref_primary_10_1631_jzus_B1400095
crossref_primary_10_1016_j_amjcard_2015_07_007
crossref_primary_10_1093_eurheartj_ehaa598
crossref_primary_10_1631_jzus_B1200306
crossref_primary_10_1016_j_jcrc_2017_11_030
crossref_primary_10_1016_j_ajem_2019_04_003
crossref_primary_10_1016_j_jacc_2012_11_019
crossref_primary_10_1097_JIM_0000000000000232
crossref_primary_10_1177_2048872617719650
crossref_primary_10_17802_2306_1278_2021_10_2_102_112
crossref_primary_10_1016_j_ijcard_2015_10_020
crossref_primary_10_1016_j_crvasa_2015_09_006
crossref_primary_10_1080_16878507_2019_1594129
crossref_primary_10_1016_j_recesp_2021_03_005
crossref_primary_10_1586_ern_12_163
crossref_primary_10_1016_j_amjcard_2013_06_009
crossref_primary_10_7759_cureus_26795
crossref_primary_10_15829_1728_8800_2013_2_52_57
crossref_primary_10_1016_j_pharmthera_2011_12_010
Cites_doi 10.1016/0003-4975(93)90468-W
10.1161/01.CIR.73.2.294
10.1161/01.cir.0000089042.80722.7a
10.1016/0735-1097(91)90739-V
10.1016/S0002-9149(03)00625-8
10.1016/S0735-1097(96)00542-6
10.1161/01.CIR.0000079054.75843.7A
10.1378/chest.108.1.89
10.1016/S0002-9149(01)01471-0
10.1161/01.CIR.81.2.477
10.1016/0002-9149(91)90010-I
10.1378/chest.124.2.565
10.1016/0003-4975(95)00863-2
10.1016/0735-1097(92)90315-E
10.1378/chest.109.2.565
10.1016/S0002-8703(96)90165-9
10.1016/S0002-9149(97)00385-8
10.1016/S0003-4975(10)60426-2
10.1016/S0140-6736(73)93065-1
10.1016/0002-8703(58)90236-9
10.1016/S0003-4975(01)02625-X
10.1016/S0167-5273(98)00372-6
10.1378/chest.81.5.643
10.1016/0735-1097(96)00008-3
10.1067/mhj.2002.123840
10.1016/0002-9343(71)90179-3
10.1016/S0735-1097(86)80177-2
10.1016/S0735-1097(98)00582-8
10.1016/0002-9149(91)90879-P
10.1016/0735-1097(93)90182-Z
10.1378/chest.92.2.219
10.1016/S0894-7317(00)90028-2
ContentType Journal Article
Copyright 2015 INIST-CNRS
Copyright_xml – notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/CIRCULATIONAHA.109.934968
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage 1909
ExternalDocumentID 20975001
23437314
10_1161_CIRCULATIONAHA_109_934968
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.-D
.3C
.55
.XZ
.Z2
01R
0R~
0ZK
18M
1J1
29B
2FS
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAEJM
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AARTV
AASOK
AAUEB
AAWTL
AAXQO
AAYOK
AAYXX
ABBUW
ABDIG
ABJNI
ABOCM
ABPMR
ABPXF
ABQRW
ABXVJ
ABZAD
ACCJW
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACOAL
ACRKK
ACWDW
ACWRI
ACXNZ
ACZKN
ADBBV
ADCYY
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFCHL
AFDTB
AFEXH
AFFNX
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJJEV
AJNWD
AJNYG
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
ASPBG
AVWKF
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C1A
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GX1
H0~
H13
HZ~
IKREB
IKYAY
IN~
J5H
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
M18
N9A
N~7
N~B
O9-
OAG
OAH
OBH
OCB
ODMTH
OGEVE
OHH
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RLZ
S4R
S4S
T8P
TEORI
TR2
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
YSK
YYM
YZZ
ZFV
ZY1
ZZMQN
~H1
.GJ
1CY
41~
AAQKA
AASCR
AASXQ
ABASU
ABVCZ
ABXYN
ABZZY
ACIJW
ACLDA
ACRZS
ACXJB
ADFPA
AEBDS
AFBFQ
AFMBP
AFSOK
AHQVU
AKCTQ
AKULP
ALMTX
AMKUR
AOHHW
AOQMC
BS7
EEVPB
ERAAH
FEDTE
GNXGY
GQDEL
HLJTE
HVGLF
H~9
IPNFZ
IQODW
MVM
N4W
NEJ
N~M
OCUKA
ODA
OHT
ORVUJ
P-K
R58
RIG
TSPGW
WHG
YQJ
YXB
YYP
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADKSD
ID FETCH-LOGICAL-c397t-9ac48e637bab482b1a785f5428b0105fea2c7251465080fde31ef07ea6d0df733
ISSN 0009-7322
1524-4539
IngestDate Sat Sep 27 20:58:48 EDT 2025
Mon Jul 21 05:33:04 EDT 2025
Wed Apr 02 07:17:10 EDT 2025
Tue Jul 01 02:05:49 EDT 2025
Thu Apr 24 22:56:08 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 19
Keywords Myocardial infarction
Prognosis
death
Cardiac tamponade
Rupture
Cardiovascular disease
Sudden
Coronary heart disease
Myocardial disease
ST elevation
cardiac rupture
Pericardial Effusion
Pericardial disease
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c397t-9ac48e637bab482b1a785f5428b0105fea2c7251465080fde31ef07ea6d0df733
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.109.934968
PMID 20975001
PQID 763257522
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_763257522
pubmed_primary_20975001
pascalfrancis_primary_23437314
crossref_citationtrail_10_1161_CIRCULATIONAHA_109_934968
crossref_primary_10_1161_CIRCULATIONAHA_109_934968
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-11-09
PublicationDateYYYYMMDD 2010-11-09
PublicationDate_xml – month: 11
  year: 2010
  text: 2010-11-09
  day: 09
PublicationDecade 2010
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2010
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References Pollack H (e_1_3_3_22_2) 1994; 128
e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
(e_1_3_3_21_2) 1988; 2
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_3_2
20974994 - Circulation. 2010 Nov 9;122(19):1898-9
References_xml – ident: e_1_3_3_29_2
  doi: 10.1016/0003-4975(93)90468-W
– ident: e_1_3_3_10_2
  doi: 10.1161/01.CIR.73.2.294
– ident: e_1_3_3_30_2
  doi: 10.1161/01.cir.0000089042.80722.7a
– ident: e_1_3_3_9_2
  doi: 10.1016/0735-1097(91)90739-V
– ident: e_1_3_3_16_2
  doi: 10.1016/S0002-9149(03)00625-8
– ident: e_1_3_3_14_2
  doi: 10.1016/S0735-1097(96)00542-6
– ident: e_1_3_3_33_2
  doi: 10.1161/01.CIR.0000079054.75843.7A
– ident: e_1_3_3_5_2
  doi: 10.1378/chest.108.1.89
– ident: e_1_3_3_25_2
  doi: 10.1016/S0002-9149(01)01471-0
– ident: e_1_3_3_3_2
  doi: 10.1161/01.CIR.81.2.477
– ident: e_1_3_3_8_2
  doi: 10.1016/0002-9149(91)90010-I
– ident: e_1_3_3_26_2
  doi: 10.1378/chest.124.2.565
– ident: e_1_3_3_34_2
  doi: 10.1016/0003-4975(95)00863-2
– ident: e_1_3_3_4_2
  doi: 10.1016/0735-1097(92)90315-E
– ident: e_1_3_3_13_2
  doi: 10.1378/chest.109.2.565
– ident: e_1_3_3_12_2
  doi: 10.1016/S0002-8703(96)90165-9
– ident: e_1_3_3_15_2
  doi: 10.1016/S0002-9149(97)00385-8
– volume: 128
  start-page: 446
  year: 1994
  ident: e_1_3_3_22_2
  article-title: Effect of nitrates on the frequency of left ventricular free wall rupture complicating acute myocardial infarction: a case-controlled study
  publication-title: Am Heart J
– ident: e_1_3_3_28_2
  doi: 10.1016/S0003-4975(10)60426-2
– volume: 2
  start-page: 349
  year: 1988
  ident: e_1_3_3_21_2
  article-title: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2: ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
  publication-title: Lancet
– ident: e_1_3_3_27_2
  doi: 10.1016/S0140-6736(73)93065-1
– ident: e_1_3_3_7_2
  doi: 10.1016/0002-8703(58)90236-9
– ident: e_1_3_3_19_2
  doi: 10.1016/S0003-4975(01)02625-X
– ident: e_1_3_3_31_2
  doi: 10.1016/S0167-5273(98)00372-6
– ident: e_1_3_3_32_2
  doi: 10.1378/chest.81.5.643
– ident: e_1_3_3_23_2
  doi: 10.1016/0735-1097(96)00008-3
– ident: e_1_3_3_6_2
  doi: 10.1067/mhj.2002.123840
– ident: e_1_3_3_11_2
  doi: 10.1016/0002-9343(71)90179-3
– ident: e_1_3_3_2_2
  doi: 10.1016/S0735-1097(86)80177-2
– ident: e_1_3_3_24_2
  doi: 10.1016/S0735-1097(98)00582-8
– ident: e_1_3_3_18_2
  doi: 10.1016/0002-9149(91)90879-P
– ident: e_1_3_3_17_2
  doi: 10.1016/0735-1097(93)90182-Z
– ident: e_1_3_3_20_2
  doi: 10.1378/chest.92.2.219
– ident: e_1_3_3_35_2
  doi: 10.1016/S0894-7317(00)90028-2
– reference: 20974994 - Circulation. 2010 Nov 9;122(19):1898-9
SSID ssj0006375
Score 2.254215
Snippet Hospital prognosis of moderate to severe pericardial effusion (MPE; ≥10 mm) in ST-elevation myocardial infarction is largely unknown. Data from 446...
Hospital prognosis of moderate to severe pericardial effusion (MPE; ≥10 mm) in ST-elevation myocardial infarction is largely unknown.BACKGROUNDHospital...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 1902
SubjectTerms Aged
Aged, 80 and over
Atrial Fibrillation - epidemiology
Biological and medical sciences
Blood and lymphatic vessels
Cardiac Tamponade - complications
Cardiac Tamponade - mortality
Cardiac Tamponade - therapy
Cardiology. Vascular system
Coronary heart disease
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Female
Heart
Heart Injuries - epidemiology
Heart Rupture, Post-Infarction - epidemiology
Hematocrit
Hospital Mortality
Humans
Male
Medical sciences
Middle Aged
Myocardial Infarction - complications
Myocardial Infarction - mortality
Myocardial Infarction - surgery
Myocardial Infarction - therapy
Pericardial Effusion - etiology
Pericardial Effusion - therapy
Pericarditis - epidemiology
Prognosis
Survival Rate
Treatment Outcome
Title Hospital Outcome of Moderate to Severe Pericardial Effusion Complicating ST-Elevation Acute Myocardial Infarction
URI https://www.ncbi.nlm.nih.gov/pubmed/20975001
https://www.proquest.com/docview/763257522
Volume 122
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahgzIYY2t3yS5Fg7GX4s6R5dujF9wlI1khF8ibkRwJCqndpfZD-w_7r3YkW7YzUtbtJSQOsrG_z0ffOTo6B6HPxPYY57ZrScf1LLomgcU8zq2Q-qFwhAsiQ20Unv70Rkv6Y-Wuer37TtZSWfCz9G7vvpL_QRWOAa5ql-w_INucFA7Ad8AXPgFh-HwUxqbpx-lFWcD5tfuvm5uBgFSici7gloTKcgcotnqLSCxlqQJk2hBUATtVknthxRtRRWdPo1TlDkxvczNmnEl4HRoETV2Dy21a9_7a19KnE2I4H39fxrNoXmXlllftQn40m0Xf4nm9FFEt2rfR1XkMf-tEXLBmWSP-hxezBfBnMonMQCFZN3qhMkEGlt3ayH1VKHT04nKjUoR2LHdo-Q7ZtdyEdCkadgwx6BzSmdThZ7h_wvDUhDEcz4bLSVV-eBSpEltnoaqkH7SzpMkM-GPybFIaiaOKRKmW6k-IDzJO7TtftdlGnuO7pqmfuo1D9Km-_NcHL74jlZ5dsxt4a2XVbuVhf0jrosUL9Lx2aHBUsfMl6onsCB1HGSvyq1v8BesUY712c4QOp3UmxzH6ZbiLa-7iXGLDXVzkuOIu7nAXG-7iLndxl7tYcxe33MUtd1-h5Xm8GI6suv2HlYJILqyQpTQQ8OA44zQgfMD8wJUu-MtctXWVgpHUB3lOlZNhy7VwBkLavmDe2l5L33Feo4Msz8RbhCWTklJXCE4leAxrRlNCGZCCE4_LlPRRYJ50kta18VWLlk2ifWRvkOyCpPI2kgqkPiLN0OuqQMxjBp3swNmMNCzqI2zwTcDeq0U8lom8vElAD8AsC15TH72pcG8H2yHof3vw7m9nf4-etu_iB3RQbEvxEbR1wU80a38DT2bKQQ
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hospital+Outcome+of+Moderate+to+Severe+Pericardial+Effusion+Complicating+ST-Elevation+Acute+Myocardial+Infarction&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=FIGUERAS%2C+Jaume&rft.au=BARRABES%2C+Jos%C3%A9+A&rft.au=SERRA%2C+Vicens&rft.au=CORTADELLAS%2C+Josefa&rft.date=2010-11-09&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0009-7322&rft.volume=122&rft.issue=19&rft.spage=1902&rft.epage=1909&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.109.934968&rft.externalDBID=n%2Fa&rft.externalDocID=23437314
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon